In Brief: NDMA label reform efforts
This article was originally published in The Tan Sheet
Executive Summary
NDMA label reform efforts: Association presented with special recognition award for "major contributions to the labeling of nonprescription drugs" by FDA Center for Drug Evaluation & Research. Signed by CDER Director Janet Woodcock, MD, the award acknowledges the Nonprescription Drug Manufacturers Association's "whole-hearted effort in partnership with the agency to provide clear and understandable labels for nonprescription drugs." ODE V Director Michael Weintraub, MD, and Division of OTC Drug Evaluation Director Debra Bowen, MD, presented the award to NDMA Senior VP and Director of Science & Technology William Soller, PhD, at the Jan. 23 joint meeting of the Nonprescription Drugs and Cardiovascular & Renal Drugs Advisory Committees. The agency anticipates publication of its long-awaited OTC labeling regs in the very near future...